Dr. The company will address these concerns within the given timeframe. Reddy’s Laboratories faced USFDA scrutiny at its New York API facility, receiving a Form 483 with two observations after a GMP inspection concluded on May 16, 2025.
Dr Reddy's receives two USFDA observations for New York API facility
Dr. The company will address these concerns within the given timeframe. Reddy’s Laboratories faced USFDA scrutiny at its New York API facility, receiving a Form 483 with two observations after a GMP inspection concluded on …